A new application of isoindole fluorophore derivative in sitagliptin antidiabetic medication assay: Application to dosage forms and biological fluid evaluation
Luminescence · 2023
DOI: 10.1002/bio.4502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Luminescence, 2023. Verfasst von Mohamed A El Hamd und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia. Hauptthemen laut MEDLINE: Sitagliptin Phosphate, Metformin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Deanship of Scientific Research at Shaqra University.
Abstract (Originalsprache)
Dipeptidyl peptidase‐4 enzyme suppressant is a unique category of oral antidiabetic medication. Sitagliptin (STG) is a perfect member of this category and is pharmaceutically marketed alone or in combination with metformin. Here, the ideal application of an isoindole derivative for STG assay was developed using a feasible, easy‐to‐use, economic, and affordable method. STG as an amino group donor can form a luminescent derivative: isoindole on interaction with o ‐phthalaldehyde and the existence of (2‐mercaptoethanol) 0.02% (v/v) as a thiol group donor. Excitation (339.7 nm) and emission (434.6 nm) wavelengths were used to monitor the isoindole fluorophore yield; moreover, each experimental variable was carefully investigated and adjusted. The calibration graph was constructed by plotting fluorescence intensities against STG concentrations, and controlled linearity was observed at concentrations ranging from 50 to 1000 ng/ml. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use guidelines were analyzed in depth to prove the technique validation. The implementation of the present technique was extended successfully to the evaluation of various types of STG dose forms and spiking samples of human plasma and urine. The developed technique was shown to be an effective, simple, and quick replacement for quality control and clinical study evaluation of STG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia.
- Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt.
- Department of Chemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.
ORCID-Profile: Mohamed A El Hamd, Ahmed A Abu-Hassan
Förderung
- Deanship of Scientific Research at Shaqra University
Zitieren
APA
El Hamd, M. A., Soltan, O. M., Abdelrahman, K. S., Alsaggaf, W. T., & Abu-Hassan, A. A. (2023). A new application of isoindole fluorophore derivative in sitagliptin antidiabetic medication assay: Application to dosage forms and biological fluid evaluation. Luminescence. https://doi.org/10.1002/bio.4502
Vancouver
El Hamd MA, Soltan OM, Abdelrahman KS, Alsaggaf WT, Abu-Hassan AA. A new application of isoindole fluorophore derivative in sitagliptin antidiabetic medication assay: Application to dosage forms and biological fluid evaluation. Luminescence. 2023. doi:10.1002/bio.4502
BibTeX
@article{ElHamd2023,
author = {El Hamd, Mohamed A and Soltan, Osama M and Abdelrahman, Kamal S and Alsaggaf, Wejdan T and Abu-Hassan, Ahmed A},
title = {A new application of isoindole fluorophore derivative in sitagliptin antidiabetic medication assay: Application to dosage forms and biological fluid evaluation},
journal = {Luminescence},
year = {2023},
doi = {10.1002/bio.4502}
}
EUVIMED